                         SEQUENCE LISTING

<110>  Illumina, Inc.
       Illumina Singapore PTE. LTD.
       Illumina Cambridge Limited
 
<120>  Systems and Methods for Detecting Multiple Analytes

<130>  P/82825.WO01

<150>  US 62/916,073
<151>  2019-10-16

<150>  US 63/014,913
<151>  2020-04-24

<150>  US 63/014,905
<151>  2020-04-24

<160>  8     

<170>  PatentIn version 3.5

<210>  1
<211>  36
<212>  DNA
<213>  Artificial

<220>
<223>  Recognition sequence 1111'

<400>  1
aaagtctaat ccgtccctgc ctctatatct ccactc                                 36


<210>  2
<211>  36
<212>  DNA
<213>  Artificial

<220>
<223>  Recognition sequence 1111''

<400>  2
cacatttaca gacctcaacc tacctccaac tctcac                                 36


<210>  3
<211>  88
<212>  DNA
<213>  Artificial

<220>
<223>  Amplification template 1113'

<400>  3
atctatctat ctatctatct atctatctat ctatctatct atcttctgag tggagatata       60

gaggcaggga cggattagac tttttttt                                          88


<210>  4
<211>  88
<212>  DNA
<213>  Artificial

<220>
<223>  Amplification template 1113''

<400>  4
gtctgtctgt ctgtctgtct gtctgtctgt ctgtctgtct gtcttctgtg agagttggag       60

gtaggttgag gtctgtaaat gtgttttt                                          88


<210>  5
<211>  36
<212>  DNA
<213>  Artificial

<220>
<223>  Trigger oligonucleotide

<400>  5
aaagtctaat ccgtccctgc ctctatatct ccactc                                 36


<210>  6
<211>  36
<212>  DNA
<213>  Artificial

<220>
<223>  Trigger oligonucleotide

<400>  6
gcattctttc ttgaggaggg cagcaaacgg gaagag                                 36


<210>  7
<211>  36
<212>  DNA
<213>  Artificial

<220>
<223>  Trigger oligonucleotide

<400>  7
cacttcatat cactcactcc caatctctat ctaccc                                 36


<210>  8
<211>  36
<212>  DNA
<213>  Artificial

<220>
<223>  Trigger oligonucleotide

<400>  8
cacatttaca gacctcaacc tacctccaac tctcac                                 36


